Are you surprised!!!!!!!!!!!!
Yes, it is true “Article One Partners” is offering individuals a cash reward of up to US$50,000 and the possibility of profit sharing. All you have to do is provide clear and concrete evidence for or against specific patents.
Article One Partners, an online community and a for-profit group formed by a group of patent attorneys and financial advisors, provides the general public an opportunity to come up with proofs for the invalidation of a valid patent as by doing this they have widest possible base of people to find the evidence required to prove or disprove a patent claim. In return of these evidences, company pay US$50,000 to the persons who could come up with invalidating prior art.
Recently they have made “Montelukast Sodium” as their target. The U.S. Patent and Trademark Office (PTO) ordered the reexamination of Merck’s biggest selling product, Singulair. The challenged patent, US 5,565,473 was granted on 15/10/1996. This patent covers montelukast sodium, the active ingredient in allergy and asthma drug.
For more information for “Article One Partners” visit the site http://www.articleonepartners.com/
